Kaur, M., Rai, J., Bal, B.S. and Kaur, J. 2017. The impact of three combinations vildagliptin/metformin, vildagliptin/pioglitazone, and metformin/pioglitazone on glycemic control and atherogenic dyslipidemia in patients with Type 2 diabetes mellitus. International Journal of Basic & Clinical Pharmacology. 3, 5 (Jan. 2017), 902–907.